 | • レポートコード：MRC2-11QY12759 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は結核ワクチンのグローバル市場について調査・分析したレポートです。種類別（免疫療法ワクチン、ブースターワクチン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別結核ワクチンの競争状況、市場シェア ・世界の結核ワクチン市場：種類別市場規模 2015年-2020年（免疫療法ワクチン、ブースターワクチン、その他） ・世界の結核ワクチン市場：種類別市場規模予測 2021年-2026年（免疫療法ワクチン、ブースターワクチン、その他） ・世界の結核ワクチン市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の結核ワクチン市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の結核ワクチン市場分析：米国、カナダ ・ヨーロッパの結核ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの結核ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の結核ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの結核ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Merck、Serum Institute of India、GlaxoSmithKline、Japan BCG Lab、IDT Biologics、GreenSignal Bio Pharma、Taj Pharmaceuticals、Bavarian Nordic、China National Biotec Group ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.
Market Analysis and Insights: Global Tuberculosis Vaccines Market
The global Tuberculosis Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tuberculosis Vaccines Scope and Market Size
Tuberculosis Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Tuberculosis Vaccines market is segmented into
Immunotherapeutic Vaccines
Booster Vaccines
Others
Segment by Application, the Tuberculosis Vaccines market is segmented into
Hospitals
Clinics
Others
Regional and Country-level Analysis
The Tuberculosis Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tuberculosis Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tuberculosis Vaccines Market Share Analysis
Tuberculosis Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tuberculosis Vaccines business, the date to enter into the Tuberculosis Vaccines market, Tuberculosis Vaccines product introduction, recent developments, etc.
The major vendors covered:
Sanofi
Merck
Serum Institute of India
GlaxoSmithKline
Japan BCG Lab
IDT Biologics
GreenSignal Bio Pharma
Taj Pharmaceuticals
Bavarian Nordic
China National Biotec Group
1 Study Coverage
1.1 Tuberculosis Vaccines Product Introduction
1.2 Market Segments
1.3 Key Tuberculosis Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Vaccines Market Size Growth Rate by Type
1.4.2 Immunotherapeutic Vaccines
1.4.3 Booster Vaccines
1.4.4 Others
1.5 Market by Application
1.5.1 Global Tuberculosis Vaccines Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tuberculosis Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Tuberculosis Vaccines Revenue 2015-2026
2.1.2 Global Tuberculosis Vaccines Sales 2015-2026
2.2 Global Tuberculosis Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tuberculosis Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tuberculosis Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Tuberculosis Vaccines Competitor Landscape by Players
3.1 Tuberculosis Vaccines Sales by Manufacturers
3.1.1 Tuberculosis Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Tuberculosis Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Tuberculosis Vaccines Revenue by Manufacturers
3.2.1 Tuberculosis Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Tuberculosis Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tuberculosis Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tuberculosis Vaccines Revenue in 2019
3.2.5 Global Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tuberculosis Vaccines Price by Manufacturers
3.4 Tuberculosis Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Tuberculosis Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tuberculosis Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Tuberculosis Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Vaccines Market Size by Type (2015-2020)
4.1.1 Global Tuberculosis Vaccines Sales by Type (2015-2020)
4.1.2 Global Tuberculosis Vaccines Revenue by Type (2015-2020)
4.1.3 Tuberculosis Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tuberculosis Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Tuberculosis Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Tuberculosis Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Tuberculosis Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tuberculosis Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Vaccines Market Size by Application (2015-2020)
5.1.1 Global Tuberculosis Vaccines Sales by Application (2015-2020)
5.1.2 Global Tuberculosis Vaccines Revenue by Application (2015-2020)
5.1.3 Tuberculosis Vaccines Price by Application (2015-2020)
5.2 Tuberculosis Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Tuberculosis Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Tuberculosis Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Tuberculosis Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Tuberculosis Vaccines by Country
6.1.1 North America Tuberculosis Vaccines Sales by Country
6.1.2 North America Tuberculosis Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tuberculosis Vaccines Market Facts & Figures by Type
6.3 North America Tuberculosis Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Tuberculosis Vaccines by Country
7.1.1 Europe Tuberculosis Vaccines Sales by Country
7.1.2 Europe Tuberculosis Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tuberculosis Vaccines Market Facts & Figures by Type
7.3 Europe Tuberculosis Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Tuberculosis Vaccines by Region
8.1.1 Asia Pacific Tuberculosis Vaccines Sales by Region
8.1.2 Asia Pacific Tuberculosis Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tuberculosis Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Tuberculosis Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Tuberculosis Vaccines by Country
9.1.1 Latin America Tuberculosis Vaccines Sales by Country
9.1.2 Latin America Tuberculosis Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tuberculosis Vaccines Market Facts & Figures by Type
9.3 Central & South America Tuberculosis Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Vaccines by Country
10.1.1 Middle East and Africa Tuberculosis Vaccines Sales by Country
10.1.2 Middle East and Africa Tuberculosis Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tuberculosis Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Tuberculosis Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Tuberculosis Vaccines Products Offered
11.1.5 Sanofi Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Tuberculosis Vaccines Products Offered
11.2.5 Merck Related Developments
11.3 Serum Institute of India
11.3.1 Serum Institute of India Corporation Information
11.3.2 Serum Institute of India Description and Business Overview
11.3.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Serum Institute of India Tuberculosis Vaccines Products Offered
11.3.5 Serum Institute of India Related Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description and Business Overview
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Tuberculosis Vaccines Products Offered
11.4.5 GlaxoSmithKline Related Developments
11.5 Japan BCG Lab
11.5.1 Japan BCG Lab Corporation Information
11.5.2 Japan BCG Lab Description and Business Overview
11.5.3 Japan BCG Lab Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Japan BCG Lab Tuberculosis Vaccines Products Offered
11.5.5 Japan BCG Lab Related Developments
11.6 IDT Biologics
11.6.1 IDT Biologics Corporation Information
11.6.2 IDT Biologics Description and Business Overview
11.6.3 IDT Biologics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 IDT Biologics Tuberculosis Vaccines Products Offered
11.6.5 IDT Biologics Related Developments
11.7 GreenSignal Bio Pharma
11.7.1 GreenSignal Bio Pharma Corporation Information
11.7.2 GreenSignal Bio Pharma Description and Business Overview
11.7.3 GreenSignal Bio Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GreenSignal Bio Pharma Tuberculosis Vaccines Products Offered
11.7.5 GreenSignal Bio Pharma Related Developments
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Corporation Information
11.8.2 Taj Pharmaceuticals Description and Business Overview
11.8.3 Taj Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Taj Pharmaceuticals Tuberculosis Vaccines Products Offered
11.8.5 Taj Pharmaceuticals Related Developments
11.9 Bavarian Nordic
11.9.1 Bavarian Nordic Corporation Information
11.9.2 Bavarian Nordic Description and Business Overview
11.9.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bavarian Nordic Tuberculosis Vaccines Products Offered
11.9.5 Bavarian Nordic Related Developments
11.10 China National Biotec Group
11.10.1 China National Biotec Group Corporation Information
11.10.2 China National Biotec Group Description and Business Overview
11.10.3 China National Biotec Group Sales, Revenue and Gross Margin (2015-2020)
11.10.4 China National Biotec Group Tuberculosis Vaccines Products Offered
11.10.5 China National Biotec Group Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Tuberculosis Vaccines Products Offered
11.1.5 Sanofi Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tuberculosis Vaccines Market Estimates and Projections by Region
12.1.1 Global Tuberculosis Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Tuberculosis Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Tuberculosis Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Tuberculosis Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Tuberculosis Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Tuberculosis Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Tuberculosis Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Tuberculosis Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Tuberculosis Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Tuberculosis Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tuberculosis Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tuberculosis Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tuberculosis Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tuberculosis Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Tuberculosis Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Tuberculosis Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Tuberculosis Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Tuberculosis Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tuberculosis Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tuberculosis Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tuberculosis Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tuberculosis Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tuberculosis Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tuberculosis Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Tuberculosis Vaccines Market Segments
Table 2. Ranking of Global Top Tuberculosis Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tuberculosis Vaccines Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Immunotherapeutic Vaccines
Table 5. Major Manufacturers of Booster Vaccines
Table 6. Major Manufacturers of Others
Table 7. Global Tuberculosis Vaccines Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 8. Global Tuberculosis Vaccines Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 9. Global Tuberculosis Vaccines Sales by Regions 2015-2020 (K Doses)
Table 10. Global Tuberculosis Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global Tuberculosis Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Tuberculosis Vaccines Sales by Manufacturers (2015-2020) (K Doses)
Table 13. Global Tuberculosis Vaccines Sales Share by Manufacturers (2015-2020)
Table 14. Global Tuberculosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Tuberculosis Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Vaccines as of 2019)
Table 16. Tuberculosis Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Tuberculosis Vaccines Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Tuberculosis Vaccines Price (2015-2020) (USD/Dose)
Table 19. Tuberculosis Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Tuberculosis Vaccines Product Type
Table 21. Date of International Manufacturers Enter into Tuberculosis Vaccines Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 24. Global Tuberculosis Vaccines Sales Share by Type (2015-2020)
Table 25. Global Tuberculosis Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Tuberculosis Vaccines Revenue Share by Type (2015-2020)
Table 27. Tuberculosis Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 28. Global Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 29. Global Tuberculosis Vaccines Sales Share by Application (2015-2020)
Table 30. North America Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 31. North America Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 32. North America Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 34. North America Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 35. North America Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Table 36. North America Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 37. North America Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Table 38. Europe Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 39. Europe Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 40. Europe Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 42. Europe Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 43. Europe Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Table 44. Europe Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 45. Europe Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Tuberculosis Vaccines Sales by Region (2015-2020) (K Doses)
Table 47. Asia Pacific Tuberculosis Vaccines Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Tuberculosis Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Tuberculosis Vaccines Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 51. Asia Pacific Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 53. Asia Pacific Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Table 54. Latin America Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 55. Latin America Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 58. Latin America Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 59. Latin America Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Table 60. Latin America Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 61. Latin America Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 63. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 67. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 69. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Major Businesses
Table 72. Sanofi Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 73. Sanofi Product
Table 74. Sanofi Recent Development
Table 75. Merck Corporation Information
Table 76. Merck Description and Major Businesses
Table 77. Merck Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Merck Product
Table 79. Merck Recent Development
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Major Businesses
Table 82. Serum Institute of India Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Serum Institute of India Product
Table 84. Serum Institute of India Recent Development
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Major Businesses
Table 87. GlaxoSmithKline Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Product
Table 89. GlaxoSmithKline Recent Development
Table 90. Japan BCG Lab Corporation Information
Table 91. Japan BCG Lab Description and Major Businesses
Table 92. Japan BCG Lab Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Japan BCG Lab Product
Table 94. Japan BCG Lab Recent Development
Table 95. IDT Biologics Corporation Information
Table 96. IDT Biologics Description and Major Businesses
Table 97. IDT Biologics Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. IDT Biologics Product
Table 99. IDT Biologics Recent Development
Table 100. GreenSignal Bio Pharma Corporation Information
Table 101. GreenSignal Bio Pharma Description and Major Businesses
Table 102. GreenSignal Bio Pharma Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. GreenSignal Bio Pharma Product
Table 104. GreenSignal Bio Pharma Recent Development
Table 105. Taj Pharmaceuticals Corporation Information
Table 106. Taj Pharmaceuticals Description and Major Businesses
Table 107. Taj Pharmaceuticals Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Taj Pharmaceuticals Product
Table 109. Taj Pharmaceuticals Recent Development
Table 110. Bavarian Nordic Corporation Information
Table 111. Bavarian Nordic Description and Major Businesses
Table 112. Bavarian Nordic Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Bavarian Nordic Product
Table 114. Bavarian Nordic Recent Development
Table 115. China National Biotec Group Corporation Information
Table 116. China National Biotec Group Description and Major Businesses
Table 117. China National Biotec Group Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. China National Biotec Group Product
Table 119. China National Biotec Group Recent Development
Table 120. Global Tuberculosis Vaccines Sales Forecast by Regions (2021-2026) (K Doses)
Table 121. Global Tuberculosis Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Tuberculosis Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Tuberculosis Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Tuberculosis Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 125. North America: Tuberculosis Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Tuberculosis Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 127. Europe: Tuberculosis Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Tuberculosis Vaccines Sales Forecast by Region (2021-2026) (K Doses)
Table 129. Asia Pacific: Tuberculosis Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Tuberculosis Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 131. Latin America: Tuberculosis Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Tuberculosis Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 133. Middle East and Africa: Tuberculosis Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Tuberculosis Vaccines Players
Table 138. Tuberculosis Vaccines Customers List
Table 139. Tuberculosis Vaccines Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Vaccines Product Picture
Figure 2. Global Tuberculosis Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Immunotherapeutic Vaccines Product Picture
Figure 4. Booster Vaccines Product Picture
Figure 5. Others Product Picture
Figure 6. Global Tuberculosis Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Others
Figure 10. Tuberculosis Vaccines Report Years Considered
Figure 11. Global Tuberculosis Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Tuberculosis Vaccines Sales 2015-2026 (K Doses)
Figure 13. Global Tuberculosis Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Tuberculosis Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Tuberculosis Vaccines Sales Market Share by Region in 2019
Figure 16. Global Tuberculosis Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Tuberculosis Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Tuberculosis Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Tuberculosis Vaccines Revenue in 2019
Figure 20. Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Tuberculosis Vaccines Sales Market Share by Type in 2019
Figure 23. Global Tuberculosis Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Tuberculosis Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Tuberculosis Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Tuberculosis Vaccines Sales Market Share by Application in 2019
Figure 28. Global Tuberculosis Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Tuberculosis Vaccines Revenue Market Share by Application in 2019
Figure 30. North America Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 31. North America Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 33. North America Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 34. U.S. Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 35. U.S. Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Canada Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Tuberculosis Vaccines Market Share by Type in 2019
Figure 39. North America Tuberculosis Vaccines Market Share by Application in 2019
Figure 40. Europe Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 41. Europe Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 43. Europe Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 44. Germany Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Germany Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 47. France Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 49. U.K. Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Italy Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Russia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Tuberculosis Vaccines Market Share by Type in 2019
Figure 55. Europe Tuberculosis Vaccines Market Share by Application in 2019
Figure 56. Asia Pacific Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 57. Asia Pacific Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Tuberculosis Vaccines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Tuberculosis Vaccines Revenue Market Share by Region in 2019
Figure 60. China Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 61. China Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 65. South Korea Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 67. India Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Australia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Taiwan Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Indonesia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Thailand Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Malaysia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Philippines Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Vietnam Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Tuberculosis Vaccines Market Share by Type in 2019
Figure 83. Asia Pacific Tuberculosis Vaccines Market Share by Application in 2019
Figure 84. Latin America Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 85. Latin America Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 87. Latin America Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 88. Mexico Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Mexico Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Brazil Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Argentina Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Tuberculosis Vaccines Market Share by Type in 2019
Figure 95. Latin America Tuberculosis Vaccines Market Share by Application in 2019
Figure 96. Middle East and Africa Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 105. U.A.E Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Tuberculosis Vaccines Market Share by Type in 2019
Figure 107. Middle East and Africa Tuberculosis Vaccines Market Share by Application in 2019
Figure 108. North America Tuberculosis Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 109. North America Tuberculosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Tuberculosis Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 111. Europe Tuberculosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Tuberculosis Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 113. Asia Pacific Tuberculosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Tuberculosis Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 115. Latin America Tuberculosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Tuberculosis Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 117. Middle East and Africa Tuberculosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…
- 治療用ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Therapeutic Vaccines Market The global Therapeutic Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Therapeutic Vaccines Scope and Market Size Therapeutic Vaccines market is…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…